In a Feb. 19 letter to Health Resources and Services Administration (HRSA) Administrator Engels, America’s Essential Hospitals requested an extension of the comment period for the agency’s request for information (RFI) on a 340B Drug Pricing Program rebate model.
The letter notes that a rebate model would upend more than 30 years of established 340B policy and that HRSA is asking stakeholders to gather “facts, research, and evidence” on specific aspects of a hypothetical model. The association asked HRSA to extend the comment deadline to April 20; the RFI currently is scheduled to close on March 19.
The letter also was signed by the American Hospital Association, the American Society of Health-System Pharmacists, the Association of American Medical Colleges, the Catholic Health Association of the United States, the Children’s Hospital Association, and 340B Health.
Contact Director of Policy Rob Nelb, MPH, at rnelb@essentialhospitals.org or 202.585.0127 with questions.
Author